プログラム

第9回武田科学振興財団薬科学シンポジウム

Wednesday,
February 7
Session 1
・Type II CRISPR-Cas systems: biology, evolution, mechanisms, applications
Emmanuelle Charpentier : Max Planck Institute for Infection Biology, Germany
・Structures and mechanisms of genome editor enzymes
Martin Jinek : University of Zurich, Switzerland
Session 2
・Genome Engineering: Prospects and Challenges
Feng Zhang : The McGovern Institute, MIT, U.S.A.
・Molecular mechanism of CRISPR and structure-based development of genome editing tools towards gene therapy
Osamu Nureki : The University of Tokyo, Japan
Session 3
・Technologies for targeted genome and epigenome editing
J. Keith Joung : Massachusetts General Hospital / Harvard Medical School, U.S.A.
・Epigenome and genome editing of mammals
Izuho Hatada : Gunma University, Japan
・Optical manipulation of the genome
Moritoshi Sato : The University of Tokyo, Japan
Session 4
・Harnessing endogenous DNA repair pathways for precision genome editing in human iPS cells
Knut Woltjen : Kyoto University, Japan
・MMEJ-assisted genome editing in cultured cells and animals
Takashi Yamamoto : Hiroshima University, Japan
Publishing with Science
Steve Mao : Science Magazine/AAAS, U.S.A.
Thursday,
February 8
Session 5
・Biallelic genome editing of human stem cells at scale
William C. Skarnes : The Jackson Laboratory for Genomic Medicine, U.S.A.
・Development and application of CRISPR screening in mammalian cells
Kosuke Yusa : Wellcome Trust Sanger Institute, UK
Session 6
・Targeted genome editing in human skin cells
Toni Cathomen : University Medical Center Freiburg, Germany
・A CRISPR view of Human development through the lens of pluripotent stem cells
Danwei Huangfu : Memorial Sloan Kettering Cancer Center, U.S.A.
・Genome editing iPS cells towards gene therapy for Duchenne muscular dystrophy
Akitsu Hotta : Kyoto University, Japan
Session 7
・Genome-editing applied to the generation of genetically engineered rats for biomedical research
Ignacio Anegon : INSERM Center for Research in Transplantation and Immunology, France
・Efficient knock-in approaches using CRISPR-Cas9 in zygotes
Tomoji Mashimo : Osaka University, Japan
・CRISPR/Cas9 mediated genome editing in mice and its application for the study of reproduction
Masahito Ikawa : Osaka University, Japan
Session 8
・Genome editing in human stem cells, animals, and plants
Jin-Soo Kim : Institute for Basic Science / Seoul National University, Korea
・Generation of non-human primate disease model by genome editing
Erika Sasaki :Central Institute for Experimental Animals, Japan
・Therapeutic gene editing in mouse and large animal models
Yutaka Hanazono : Jichi Medical University, Japan